Plenary/Key Note Lectures

    1. 1. The Utility of FT-ICR Mass Spectrometry in the Clinical Domain: From Discovery to Targeted Proteomics
      David C. Muddiman
      Plenary Lecture, Trapped Ion Meeting, Department of Chemistry, Oxford University, London, England, 2005
    2. 2. Clinical Proteomics for Disease Diagnostics and Treatment
      David C. Muddiman
      Plenary Special Lecture, Korean Academy of Asthma, Allergy, and Clinical Immunology, Seoul, Korea, 2006
    3. 3. Discovery and Targeted Plasma Proteomics: Application to Ovarian Cancer and Cardiovascular Disease
      David C. Muddiman
      Keynote Lecture, Bascom Palmer Eye Institute, Evelyn F. and William L. McKnight Vision Research Center, University of Miami Miller School of Medicine, Miami, FL, 2006
    4. 4. Splitless nanoLC ESI-FTICR Mass Spectrometry in the Clinical Proteomics Arena – You Can Never Have Too Much Peak Capacity
      David C. Muddiman
      Keynote Lecture, 20th International Symposium on Microscale Bioseparations, Vancouver, Canada, 2007
    5. 5. Recent Advances in FT-ICR Mass Spectrometry Instrumentation
      David C. Muddiman
      55th American Society for Mass Spectrometry Conference, Indianapolis, IN, 2007
    6. 6. Implementing nanoLC-MS/MS for Global and Targeted Clinical Biomarker Characterization
      David C. Muddiman
      Howard James Keynote Lecture, Triangle Chromatography Discussion Group, Raleigh, NC, 2009
    7. 7. The Scientific Journey of a Modern Day Lavoisier Disciple. Biemann Award Plenary Lecture
      David C. Muddiman
      American Society for Mass Spectrometry, Salt Lake City, UT, 2010
    8. 8. Development and Application of Mass Spectrometry-Based Biomarker Discovery Technologies for the Early Detection of Epithelial Ovarian Cancer
      David C. Muddiman
      Centennial Lecturer, Department of Chemistry, University of Texas at Austin, 2010
    9. 9. Rational Biomarker Discovery and Validation using a Systems Approach
      David C. Muddiman
      British Mass Spectrometry Society, Cardiff, UK, 2011
    10. 10. From Innovative Technologies to Model Organisms: The Search for Biomarkers for the Detection of Early Stage Epithelial Ovarian Cancer
      David C. Muddiman
      NJ ACS MSDG Distinguished Lecture Award, New Brunswick, NJ, 2011
    11. 11. Biological Mass Spectrometry Driven by Electrospray Ionization: A Tribute to the Life and Science of John B. Fenn
      David C. Muddiman
      Inaugural Fenn Symposium, Department of Chemistry, Virginia Commonwealth University, Richmond, VA, 2011
    12. 12. New Chemical and Instrumental Tools for Exploring the Proteome, Glycome, and Lipidome
      David C. Muddiman
      AAPS/APQ Education Initiative Award/AAPS-VCU Student Chapter Invited Speaker. Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA, 2012
    13. 13. Molecular Tissue Imaging under Ambient Conditions using a Novel Imaging Source Coupled to High Resolving Power Mass Spectrometry
      David C. Muddiman
      12th Annual World Congress of the Human Proteome Organization, Yokohama, Japan, 2013
    14. 14. Innovative Chemical and Instrumental Approaches Directed at Unraveling Complex Biological Systems
      David C. Muddiman
      Lilly Endowment Analytical Sciences Seminar, Department of Chemistry and Biochemistry, Notre Dame University, Notre Dame, IN, 2013
    15. 15. Quantitative Proteomics to Understand Lignin Biosynthesis and Plant-Fungal Interactions
      David C. Muddiman
      Robert W. Holley Nobel Laureate Lectureship, Department of Plant Pathology, Cornell University, Ithaca, NY, 2013
    16. 16. Novel Glycomic and Mass Spectrometry Imaging Technologies to Effectively Address Complex Biological Questions
      David C. Muddiman
      Swedish Proteomics Society, Lund, Sweden, 2013
    17. 17. Translating Innovative Technologies into the Commercial Realm
      David C. Muddiman
      Innovative Molecular Analysis Technologies, National Cancer Institute, Bethesda, MD, 2013
    18. 18. Innovative Glycomic and Mass Spectrometry Imaging Technologies: From Biomarkers to Drug Distribution and Metabolism
      David C. Muddiman
      Humphrey Symposium Speaker, University of Vermont, Burlington, VT, 2014
    19. 19. Systems Biology and Model Organisms to Understand the Biology of Ovarian Cancer
      David C. Muddiman
      Proteomics for Translational Research, Indian Institute of Technology, Mumbai, India, 2015
    20. 20. Working Around the Cluck: A Systems Biology Approach to Understand the Origin and Biology of Ovarian Cancer
      David C. Muddiman
      Canary Center for Cancer Early Detection, Stanford University, Palo Alto, CA 2015
    21. 21. Infrared Matrix Assisted Laser Desorption Electrospray Ionization: A New Paradigm in Mass Spectrometry Imaging
      David C. Muddiman
      Chemical Instrumentation Award Lecture, 250th Meeting of the American Chemical Society, Boston, MA 2015
    22. 22. Working Around the Cluck: A Systems Biology Approach to Understand the Origin and Biology of Ovarian Cancer
      David C. Muddiman
      Cancer Institute Forum, University of Arkansas, Little Rock, AK 2015
    23. 23. Working Around the Cluck: A Systems Biology Approach to Understand the Origin and Biology of Ovarian Cancer
      David C. Muddiman
      NJ ACS MSDG Distinguished Lecture Award, Somerset, NJ 2016
    24. 24. Innovative Mass Spectrometry Chemistries and Technologies to Read the Complex Language of Biology
      David C. Muddiman
      Thermo Fisher Scientific Distinguished Scientist Lecture, Department of Chemistry, University of Montreal, Montreal, Canada 2017
    25. 25. Innovations in Mass Spectrometry Platform Technologies for Epithelial Ovarian Cancer Research
      David C. Muddiman
      Plenary Lecture, Spanish Society for Analytical Chemistry, Valencia, Spain, 2017
    26. 26. Novel Discoveries in ALS: From Proteome Profiling and Proteoforms to Non-Protein Amino Acid Level Measurements
      David C. Muddiman
      Keynote, Beijing Conference and Exhibition on Instrumental Analysis (BCEIA), 2017
    27. 27. IR-MALDESI: An Innovative Approach to Molecular Microscopy
      David C. Muddiman
      Department of Energy, BioEnergy Research Center, Duke Energy Hall, Hunt Library, NC State University, 2018
    28. 28. IR-MALDESI: An Innovative Approach to Molecular Microscopy
      David C. Muddiman
      Canadian Institute for Advanced Research, Molecular Architecture of Life, Toronto, Canada, 2018
    29. 29. Novel Discoveries in Ovarian Cancer and ALS: From Proteome Profiling to Proteoforms
      David C. Muddiman
      Howard James Keynote Speaker, Triangle Chromatography Discussion Group, North Carolina Biotechnology Center, 2018
    30. 30. Scientific Discovery and Impact Through Innovative Mass Spectrometry Measurements: From Plants and Model Organisms to Humans
      David C. Muddiman
      Foster Lecture Series, State University of New York – Buffalo, Buffalo, NY 2020